Report Highlights
The global market for precision medicine is estimated to increase from $54.2 billion in 2023 to reach $100.5 billion by 2028, at a compound annual growth rate (CAGR) of 13.2% from 2023 through 2028.
Report Includes
- 26 tables
- A comprehensive overview and an up-to-date analysis of the global market for precision medicine
- Analyses of the global market trends, with market revenue data (sales figures) for 2020-2022, forecasts for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Discussion of industry growth driving factors and major technology issues and challenges affecting the market for precision medicine as a basis for projecting demand in the next few years (2023-2028)
- Estimation of the actual market size and revenue forecast for global precision medicine market in USD million values, and corresponding market share analysis by technology type, application, end user, and region
- Insights into the recent industry structure for precision medicine technologies, competitive aspects of each product segments, increasing investment on R&D activities, market growth strategies, and company revenue share analysis
- Review of the recent patent grants and patent applications on precision medicine technologies
- Updated information on key mergers and acquisition deals, agreements, partnerships, collaborations and product launches within the global precision medicine industry
- Identification of the major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, and segmental revenues
- Detailed company profiles of the leading market players, including AstraZeneca, Bristol-Myers Squibb Co., Novartis AG, Pfizer Inc., and Johnson & Johnson
Report Scope
This study offers a global view of the solutions provided by precision medicine in the market. This report analyzes and assesses technologies such as big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and others. It also provides information about the areas in which precision medicine is used, such as oncology, central nervous system disorders, immunology, respiratory conditions, and others.
BCC Research analyzes and makes projections for each market and its segmentation and assesses the regulatory environment, pipeline products, and future aspects. The report also examines the impact of COVID, discusses emerging trends in the market, and profiles leading companies in the precision medicine market such as Pfizer, Roche, AstraZeneca, Novartis, and Thermo Fisher Scientific. The report covers the major markets of North America and Europe and emerging markets such as India, China, Japan, South America, and others.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||||||||||||||||
| Forecast period considered | 2023-2028 | ||||||||||||||||||||||
| Base year market size | $48.1 billion | ||||||||||||||||||||||
| Market size forecast | $100.5 billion | ||||||||||||||||||||||
| Growth rate | CAGR of 13.2% for the forecast period of 2023-2028 | ||||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||||
| Segments covered | Technology, Application and Region | ||||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, South America, and Middle East and Africa | ||||||||||||||||||||||
| Countries covered | U.S., Canada, Mexico, France, Germany, U.K., Italy, Spain, China, India, Australia, and Japan | ||||||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||||||
| Companies studied |
|
||||||||||||||||||||||
Frequently Asked Questions (FAQs)
- Increasing cases of chronic diseases
- Government initiatives
- Technological advancements
Analyst Credentials
Shehanaz Pathan– Assistant Manager- Life Sciences Research
Shehanaz Pathan is an experienced professional with more than a decade of industry experience in research and analysis, specializing in healthcare. She has a wide range of experience in multiple domains, such as pharmaceuticals, biotechnology, medical devices, and healthcare IT. She designs research studies and provides end-to-end analysis to clients with real-time market insights and recommendations. Academically, Shehanaz holds a master’s degree in Marketing, as well as a bachelor’s degree in Microbiology.
Related Reports
Companion Diagnostics: Technologies and Markets
The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.
Pharmacy Automation: Technologies and Global Markets
The global market for pharmacy automation is estimated to increase from $7.8 billion in 2023 to reach $12.7 billion by 2028, at a compound annual growth rate (CAGR) of 10.2% from 2023 through 2028.
Bioinformatics: Technologies and Global Markets
The global market for bioinformatics is expected to grow from $18.7 billion in 2023 to $35.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 13.6% during the forecast period of 2023-2028.
Global Blockchain Technology in Healthcare Market
The global market for blockchain technology in healthcare reached $386.8 million in 2021. The market is estimated to increase from $640.7 million in 2022 to $7.0 billion by 2027, at a compound annual growth rate (CAGR) of 61.1% from 2022 through 2027.
Recent Reports
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.
Clinical Trial Infrastructure Regional Analysis Market: Middle East and North Africa
This report provides an overview of the clinical trial infrastructure markets in the Middle East and North Africa (MENA) region. It includes a detailed examination of the market dynamics and an understanding of the MENA clinical trial landscape by study status, phase, type, results and sponsor type.
Intravenous (IV) Therapy and Vein Access: Global Markets
The global market for IV therapy and venous access devices is expected to grow from $57.0 billion in 2024 and is projected to reach $74.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.
Global Colorectal Cancer Screening and Diagnostics Market
The global market for colorectal cancer screening and diagnostic testing services is estimated to increase from $40.0 billion in 2024 to reach $46.1 billion by 2029, at a compound annual growth rate (CAGR) of 2.9% from 2024 through 2029.
Medical Imaging: A BCC Research Outlook
The global market for medical imaging is expected to grow from $63.4 billion in 2024 and is projected to reach $82.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.
Top Trending Reports
Global Diabetic Care Devices Market
The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.
Carbon Capture, Utilization & Storage Technologies
The global market for carbon capture, utilization and storage (CCUS) technologies is expected to grow from $3.4 billion in 2024 and is projected to reach $9.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.1% during the forecast period of 2024 to 2029.
2024 Semiconductor Manufacturing Research Review
This 2024 Research Review of the Semiconductor Manufacturing provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions.
2024 Medical Devices Research Review
The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.
Generative AI: Global Markets
The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More